People

Samantha Budd Haeberlein

Draig Therapeutics director representing ICG and former Draig chief medical officer, as identified in its launch announcement. Samantha Budd Haeberlein is an ALZpath director and neuroscience drug development executive. Her career includes neurodegeneration leadership at Biogen and earlier research and development roles at AstraZeneca.